STAGE IV RENAL CELL CANCER AJCC V7
Clinical trials for STAGE IV RENAL CELL CANCER AJCC V7 explained in plain language.
Never miss a new study
Get alerted when new STAGE IV RENAL CELL CANCER AJCC V7 trials appear
Sign up with your email to follow new studies for STAGE IV RENAL CELL CANCER AJCC V7, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Pill vs. placebo: can a drug stop Cancer's return after surgeons remove it?
Disease control OngoingThis study tested whether taking a drug called pazopanib for about a year could help keep kidney cancer from returning after surgeons had successfully removed all visible tumors that had spread. Patients who had no signs of cancer left after surgery were randomly assigned to take…
Matched conditions: STAGE IV RENAL CELL CANCER AJCC V7
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
Scientists test malaria drug combo against tough cancers
Disease control OngoingThis early-stage trial is testing whether combining an experimental cancer drug called MK-2206 with the malaria drug hydroxychloroquine is safe for people with advanced solid tumors, melanoma, kidney, or prostate cancer. The main goal is to find the highest dose patients can tole…
Matched conditions: STAGE IV RENAL CELL CANCER AJCC V7
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC
-
Scientists test new combo to fight spreading kidney cancer
Disease control OngoingThis study tested a new combination of two drugs, entinostat and aldesleukin, for patients with advanced kidney cancer that has spread. The goal was to find a safe dose and see if the combination could help control the cancer better than one drug alone. It involved 47 patients an…
Matched conditions: STAGE IV RENAL CELL CANCER AJCC V7
Phase: PHASE1, PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC
-
Immunotherapy tested as new hope for rare, Tough-to-Treat cancers
Disease control OngoingThis study tested whether the immunotherapy drug pembrolizumab could help control the growth of rare, advanced cancers that have spread or cannot be removed by surgery. It involved 157 patients with specific rare tumor types who had already tried standard treatments. The goal was…
Matched conditions: STAGE IV RENAL CELL CANCER AJCC V7
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 27, 2026 12:37 UTC
-
Early trial tests drug combos to help immune system fight advanced kidney cancer
Disease control OngoingThis early-stage study is testing three different immunotherapy drug combinations in patients with advanced kidney cancer that has spread. The main goal is to see which combination is safest and causes the fewest side effects when given before surgery to remove the cancer. Resear…
Matched conditions: STAGE IV RENAL CELL CANCER AJCC V7
Phase: EARLY_PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 23, 2026 15:17 UTC
-
Doctors test inhaled cancer treatment to target lung tumors
Disease control OngoingThis early-stage study is testing an inhaled form of an immune-boosting drug (aldesleukin) for people whose cancer has spread to their lungs. The main goals are to find a safe dose and see if the treatment causes side effects. Researchers also want to learn if inhaling the drug d…
Matched conditions: STAGE IV RENAL CELL CANCER AJCC V7
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 16, 2026 15:26 UTC